United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations & ProQuest (Firm). (1983). FDA's prescription to over-the-counter drug switch: Hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session on the Food and Drug Administration's policies and procedures in switching drugs from prescription to over-the-counter status, June 6, 1983. U.S. G.P.O..
Chicago Style (17th ed.) CitationUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations and ProQuest (Firm). FDA's Prescription to Over-the-counter Drug Switch: Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, First Session on the Food and Drug Administration's Policies and Procedures in Switching Drugs from Prescription to Over-the-counter Status, June 6, 1983. Washington: U.S. G.P.O., 1983.
MLA (9th ed.) CitationUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations and ProQuest (Firm). FDA's Prescription to Over-the-counter Drug Switch: Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, First Session on the Food and Drug Administration's Policies and Procedures in Switching Drugs from Prescription to Over-the-counter Status, June 6, 1983. U.S. G.P.O., 1983.